Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases

44Citations
Citations of this article
38Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cardiovascular diseases, also known as circulatory diseases, are diseases of the heart and blood vessels, and its etiology is hyperlipidemia, thick blood, atherosclerosis, and hypertension. Due to its high prevalence, disability, and mortality, it seriously threatens human health. According to reports, the incidence of cardiovascular disease is still on the rise. Rhodiola rosea is a kind of traditional Chinese medicine, which has the effects of antimyocardial ischemia-reperfusion injury, lowering blood fat, antithrombosis, and antiarrhythmia. Rhodiola rosea has various chemical components, and different chemical elements have the same pharmacological effects and medicinal values for various cardiovascular diseases. This article reviews the research on the pharmacological effects of Rhodiola rosea on cardiovascular diseases and provides references for the clinical treatment of cardiovascular diseases.

Cite

CITATION STYLE

APA

Chen, Y., Tang, M., Yuan, S., Fu, S., Li, Y., Li, Y., … Zhang, Q. (2022). Rhodiola rosea: A Therapeutic Candidate on Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity. Hindawi Limited. https://doi.org/10.1155/2022/1348795

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free